Trinity biotech announces management changes

John gillard named chief executive officer des fitzgerald named interim chief financial officer dublin, ireland, dec. 18, 2023 (globe newswire) -- trinity biotech plc (nasdaq: trib) (the “company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the promotion of john gillard, our chief financial officer, to president and chief executive officer, effective immediately. des fitzgerald, who has served as director of corporate development of trinity biotech since october 2022, has been promoted to interim chief financial officer, succeeding mr.
TRIB Ratings Summary
TRIB Quant Ranking